Overall Status

Recruiting (18)

Completed (4)

Not yet recruiting (2)

Terminated (2)

Unknown status (2)

Active, not recruiting (1)

Phase

phase 2 (11)

phase 4 (6)

n/a (3)

phase 1 (2)

early phase 1 (1)

phase 1/phase 2 (1)

phase 2/phase 3 (1)

Study Documents

Intervention Type

drug (22)

diagnostic test (2)

other (2)

biological (1)

procedure (1)

Funder Type

Other (27)

Industry (2)

Study Type

Interventional (25)

Observational (3)

Observational [Patient Registry] (1)

Hemangioendothelioma

Showing 26 - 29 of 29

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab

Recruiting

Soft Tissue Sarcoma
Bone Sarcoma

Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
+7 more

Bologna, Italy
+12 more

Nov 10, 2021

Sarcoma, Soft Tissue Trial in New York (Sunitinib)

Terminated

Has Results

Sarcoma, Soft Tissue

Sunitinib

New York, New York

Columbia University Medical Center

Oct 15, 2019

Sarcoma Trial in United States (Bevacizumab)

Completed

Has Results

Sarcoma

Bevacizumab

La Jolla, California
+4 more

Jun 20, 2018

Kaposiform Hemangioendotheliomas, Tufted Angioma, Capillary Venous Lymphatic Malformation Trial in Boston, Cincinnati

Unknown status

Kaposiform Hemangioendotheliomas
+8 more

sirolimus

Boston, Massachusetts
+1 more

Feb 3, 2015